L-Alanine, N-[(9H-fluoren-9-ylmethoxy)carbonyl]-3-[[(4-methoxyphenyl)methyl]seleno]-, 98%, 100mg

(2E)-1-(4-bromophenyl)-3-phenylprop-2-en-1-one, 98.0%, 5g

CDTA, minimo 99%, pa, ACS, 500 g, confezione in plastica.

2,5-Dioxopyrrolidin-1-yl 19-(2,5-dioxo-2H-pyrrol-1(5H)-yl)-17-oxo-4,7,10,13-tetraoxa-16-azanonadecan-1-oate, 99%, 250mg

Pipette volumetriche in plastica, 1 ml, 12 pezzi

2-(4-Bromo-2-fluoro-5-methylphenyl)-4,4,5,5-tetramethyl-1,3,2-dioxaborolane, 98%, 250mg

4-Bromo-1-(tetrahydro-2H-pyran-2-yl)-1H-pyrazole, 95.0%, 1g

Thiophene-3-carboxamidine hydrochloride, 95.0%, 5g

(R)-(4-(1-AMINOETHYL)PHENYL)METHANOL, 95.0%, 1g

2-((2-(2,6-Dioxopiperidin-3-yl)-1-oxoisoindolin-4-yl)amino)acetic acid, 98%, 100mg

2-Chloro-1-methylpyridin-1-ium 4-methylbenzenesulfonate, 95.0%, 25g

MALTOPENTAOSE, 95%, 10mg

Benzyl 2,6-dimethyl-4-oxopiperidine-1-carboxylate, 95.0%, 250mg